Top Industry Leaders in the Blood Transfusion Diagnostics Market
Latest Blood Transfusion Diagnostics Companies Updates:
Roche Diagnostics: Launched the cobas® m511 analyzer in October 2023, offering a high-throughput platform for automated ABO and Rh blood typing with advanced features for accuracy and efficiency.
Grifols, S.A.: Received FDA approval for their Procleix® Panther Fusion™ system in July 2023, enabling simultaneous testing for multiple infectious diseases in donated blood with rapid turnaround times.
Immucor, Inc.: Partnered with Google Cloud in September 2023 to develop AI-powered tools for analyzing blood donor data and predicting potential transfusion risks.
Bio-Rad Laboratories, Inc.: Introduced the Micro Typing System™ with MicroVue™ ABO/Rh cards in December 2023, providing a reliable and portable option for blood typing in resource-limited settings.
Diagnoptics for the Developing World: Received funding from the Bill & Melinda Gates Foundation in January 2024 to develop and distribute affordable, rapid blood typing tests for low- and middle-income countries.
List of Blood Transfusion Diagnostics Key companies in the market:
- Roche Diagnostics (Switzerland)
- bioMérieux (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Immucor (U.S)
- Siemens Healthineers (Germany)
- Ortho Clinical Diagnostics, Inc. (U.S.)
- Becton, Dickinson and Company (U.S.)
- Novartis AG (Switzerland)
- Beckman Coulter, Inc. (U.S.)